`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`
`C.A. No. 1:14-cv-984 (RGA)
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`LANNETT HOLDINGS, INC. AND LANNETT COMPANY, INC.’S RULE 12(b)(1)
`MOTION TO DISMISS FOR LACK OF SUBJECT MATTER JURISDITION
`
`Pursuant to Fed. R. Civ. P. 12(b)(1), Defendants Lannett Holdings, Inc. and Lannett
`
`Company, Inc. (collectively “Lannett”), by counsel, hereby move to dismiss the above-captioned
`
`action for lack of subject matter jurisdiction. For the reasons set forth in the accompanying
`
`Opening Memorandum of Points and Authorities, Defendants’ Motion to Dismiss should be
`
`granted.
`
` FOX ROTHSCHILD LLP
`
`
`
`
`
`
` /s/ Austen C. Endersby
`Seth A. Niederman, Esquire (#4588)
`Austen C. Endersby, Esquire (#5161)
`Citizens Bank Center
`919 North Market Street, Suite 300
`Wilmington, DE 19801
`(302) 654-7444
`sniederman@foxrothschild.com
`aendersby@foxrothschild.com
`
`Attorneys for Defendants Lannett Holdings,
`Inc. and Lannett Company, Inc.
`
`
`
`
`
`Of Counsel:
`Joseph F. Posillico, Esq.
`FOX ROTHSCHILD LLP
`2000 Market Street, 20th Floor
`Philadelphia, PA 19103-3222
`(215) 299-2000
`
`
`
`Dated: September 24, 2014
`
`
`
`ACTIVE 27526659v1 09/24/2014
`
`
`
`
`
`
`
`
`IMPAX LABORATORIES, INC. and
`ASTRAZENECA AB,
`
`Plaintiffs,
`
`v.
`
`
`LANNETT HOLDINGS, INC., and
`LANNETT COMPANY, INC.,
`
`
`Defendants.
`
`Page 1 of 1
`
`AstraZeneca Exhibit 2007
`Lannett v. AstraZeneca
`IPR2015-01629